332 related articles for article (PubMed ID: 3274463)
1. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
Ebel H; Lange H
Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
[No Abstract] [Full Text] [Related]
2. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
[No Abstract] [Full Text] [Related]
3. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
[No Abstract] [Full Text] [Related]
4. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
Restifo AC; Petrie JJ; Rigby RJ; Hardie IR; Jacob CK; Russ GR; Mathew TH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1604-5. PubMed ID: 2652522
[No Abstract] [Full Text] [Related]
5. Adrenal function as an index of the immunosuppressive activity of glucocorticoids (prednisolone) in renal allograft recipients.
Kozaki M; Hirano T; Oka K
Transplant Proc; 1987 Feb; 19(1 Pt 3):2237-9. PubMed ID: 3079076
[No Abstract] [Full Text] [Related]
6. Diagnosis of renal allograft rejection by analysis of infiltrating cell profiles: an assessment of cyclosporine, azathioprine/prednisolone, and triple therapy.
McWhinnie DL; Azevedo LS; Carter NP; Cranston D; Jones R; Wood RF; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1633-4. PubMed ID: 3152633
[No Abstract] [Full Text] [Related]
7. Cyclosporine to azathioprine conversion in cadaveric renal transplants.
Gonwa TA; Nghiem DD; Corry RJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2018-20. PubMed ID: 3079068
[No Abstract] [Full Text] [Related]
8. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
Henny FC; Kootte AM; van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
[No Abstract] [Full Text] [Related]
9. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
[No Abstract] [Full Text] [Related]
10. Diabetes mellitus after renal transplantation.
Basri N; Aman H; Adiku W; Baraqdar A; Bonatero I; Nezamuddin N
Transplant Proc; 1992 Oct; 24(5):1780-1. PubMed ID: 1412840
[No Abstract] [Full Text] [Related]
11. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
Tegzess AM; van Son WJ; de Maar EF; Beelen JM; Sluiter WJ; Huisman RM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
[No Abstract] [Full Text] [Related]
12. Elective cyclosporine conversion from triple therapy.
Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532
[No Abstract] [Full Text] [Related]
13. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
[No Abstract] [Full Text] [Related]
14. Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation.
Weimar W; Versluis DJ; Wenting GJ; Derkx FH; Schalekamp MA; Jeekel J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1998-9. PubMed ID: 3274462
[No Abstract] [Full Text] [Related]
15. Requirements for safe prednisone discontinuation in late renal transplantation in recipients immunosuppressed with cyclosporine.
Lloveras J; Puig JM; Comerma I; Orfila A; Mir M; Masramón J; Aubia J
Transplant Proc; 1990 Aug; 22(4):1693-4. PubMed ID: 2202127
[No Abstract] [Full Text] [Related]
16. Blood eosinophilia and renal allograft rejection.
Frenken LA; Leunissen KM; van den Berg-Loonen PM; Kootstra G; van Hooff JP
Transplant Proc; 1987 Feb; 19(1 Pt 2):1584-5. PubMed ID: 3079028
[No Abstract] [Full Text] [Related]
17. Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone.
O'Connell P; d'Apice A; Walker R; Francis D; Kincaid-Smith P
Transplant Proc; 1988 Feb; 20(1):11-3. PubMed ID: 3278450
[No Abstract] [Full Text] [Related]
18. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
Maddux MS; Veremis SA; Pollak R; Mozes MF
Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
[TBL] [Abstract][Full Text] [Related]
19. Monitoring the response to anti-rejection therapy with serum neopterin.
Smillie AE; Rigby RJ; Petrie JJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
[No Abstract] [Full Text] [Related]
20. Skin test reactivity and lymphocyte subsets in cyclosporine versus azathioprine-treated renal transplant recipients.
Pomer S; Daniel V; Dreikorn K; Röhl L
Transplant Proc; 1987 Feb; 19(1 Pt 2):1568-9. PubMed ID: 3079026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
